Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma

International Journal of Cancer

Volumn 137, Issue 7, 2015, Pages 1679-1690

  Wen, Yang ^a   Han, Jing ^a   Chen, Jianguo ^b,c   Dong, Jing ^a   Xia, Yongxiang ^a   Liu, Jibin ^c   Jiang, Yue ^a   Dai, Juncheng ^a   Lu, Jianhua ^b   Jin, Guangfu ^a   Han, Jiali ^d   Wei, Qingyi ^e   Shen, Hongbing ^a   Sun, Beicheng ^a   Hu, Zhibin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b QIDONG LIVER CANCER INSTITUTE   (China)

^c Nantong Tumor Hospital   (China)

^d INDIANA UNIVERSITY   (United States)

^e DUKE CANCER INSTITUTE   (United States)

Author keywords

biomarker; early detection; hepatocellular carcinoma; miRNA; plasma

Indexed keywords

ALPHA FETOPROTEIN; MICRORNA; MICRORNA 132-3P; MICRORNA 185-5P; MICRORNA 192-5P; MICRORNA 20A-5P; MICRORNA 21-5P; MICRORNA 25-3P; MICRORNA 30A-5P; MICRORNA 320A; MICRORNA 324A-3P; MICRORNA 375; MICRORNA 92-3P; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE OVEREXPRESSION; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADULT; BLOOD; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; GENETICS; LIVER NEOPLASMS; MULTICENTER STUDY; PATHOLOGY;

ADULT; CARCINOMA, HEPATOCELLULAR; EARLY DIAGNOSIS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84943348363     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29544     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, et al., Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Ferlay J, Shin HR, Bray F, et al., Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
3. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
4. Li L, Hu Z, Zhou Z, et al., Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 2010; 70: 9798-807.
5. Hu Z, Chen X, Zhao Y, et al., Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010; 28: 1721-6.
6. Zhu C, Ren C, Han J, et al., A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer 2014; 110: 2291-9.
7. Mitchell PS, Parkin RK, Kroh EM, et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-18.
8. Arroyo JD, Chevillet JR, Kroh EM, et al., argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003-8.
9. Chen X, Hu Z, Wang W, et al., Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 2012; 130: 1620-8.
10. Zhou J, Yu L, Gao X, et al., Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 2011; 29: 4781-8.
11. Chen W, Lu F, Liu SJ, et al., Cancer risk and key components of metabolic syndrome: a population-based prospective cohort study in Chinese. Chin Med J (Engl) 2012; 125: 481-5.
12. Chen J, Parkin DM, Chen Q, et al., Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 2003; 10: 204-9.
13. Li Y, Tan W, Neo TW, et al., Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100: 1234-42.
14. Li W, Xie L, He X, et al., Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008; 123: 1616-22.
15. Wang Y, Lee AT, Ma JZ, et al., Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008; 283: 13205-15.
16. Meng F, Henson R, Wehbe-Janek H, et al., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-58.
17. Wong QW, Lung RW, Law PT, et al., MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of stathmin1. Gastroenterology 2008; 135: 257-69.
18. Huang Z, Huang D, Ni S, et al., Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127: 118-26.
19. Resnick KE, Alder H, Hagan JP, et al., The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-9.
20. Brase JC, Wuttig D, Kuner R, et al., Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 2010; 9: 306
21. He L, Thomson JM, Hemann MT, et al., A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33.
22. Schlaeger C, Longerich T, Schiller C, et al., Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 2008; 47: 511-20.
23. O'Donnell KA, Wentzel EA, Zeller KI, et al., c-Myc-regulated microRNAs modulate e2f1 expression. Nature 2005; 435: 839-43.
24. Macleod K,. pRb and E2f-1 in mouse development and tumorigenesis. Curr Opin Genet Dev 1999; 9: 31-9.
25. Zhang Z, Tang H, Wang Z, et al., MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol Cancer 2011; 10: 124.
26. Strum JC, Johnson JH, Ward J, et al., MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Mol Endocrinol 2009; 23: 1876-84.
27. Houtkooper RH, Pirinen E, Auwerx J,. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 2012; 13: 225-38.
28. Cheng HL, Mostoslavsky R, Saito S, et al., Developmental defects and p53 hyperacetylation in sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003; 100: 10794-9.
29. Firestein R, Blander G, Michan S, et al., The sirt1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008; 3: e2020.
30. Chandrasekar B, Bysani S, Mummidi S,. Cxcl16 signals via gi, phosphatidylinositol 3-kinase, akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 2004; 279: 3188-96.
31. Rieken S, Herroeder S, Sassmann A, et al., Lysophospholipids control integrin-dependent adhesion in splenic B cells through G(i) and G(12)/G(13) family G-proteins but not through G(q)/G(11). J Biol Chem 2006; 281: 36985-92.
32. Campus F, Lova P, Bertoni A, et al., Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation. J Biol Chem 2005; 280: 24386-95.
33. Foley JF, Singh SP, Cantu M, et al., Differentiation of human T cells alters their repertoire of G protein alpha-subunits. J Biol Chem 2010; 285: 35537-50.
34. Yao J, Liang LH, Zhang Y, et al., gnai1 suppresses tumor cell migration and invasion and is Post-transcriptionally regulated by Mir-320a/c/d in hepatocellular carcinoma. Cancer Biol Med 2012; 9: 234-41.
35. Ofek O, Attar-Namdar M, Kram V, et al., cb2 cannabinoid receptor targets mitogenic gi protein-cyclin d1 axis in osteoblasts. J Bone Miner Res 2011; 26: 308-16.
36. Nguyen MH, Garcia RT, Simpson PW, et al., Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology 2002; 36: 410-17.